Although anti-TGF-β antibody alone did not induce tumor growth inhibition compared with the isotype control, mice treated with a combination of anti-PD-1 and anti-TGF-β antibodies demonstrated significantly smaller tumors than mice in other groups (Fig. 4B–D and Fig. S7A–C). The gene discussed is PDCD1; the disease is neoplasm.